-
UBC9-Driven PINK1 SUMOylation Modulates Mitophagy in Parkins
2026-05-21
This study reveals that UBC9-mediated SUMOylation of PINK1 is a crucial regulator of mitophagy and oxidative stress attenuation in Parkinson’s disease models. By demonstrating a direct mechanistic link, the findings provide new insight into mitochondrial quality control as a potential therapeutic target for neurodegeneration.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Guide
2026-05-21
FITC-Concanavalin A (ConA) Conjugate enables direct, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces in immunofluorescence and flow cytometry assays. It should be used exclusively for carbohydrate-binding applications within its defined storage and stability parameters. This product is not suitable for non-glycan targets or protocols requiring unlabeled lectins.
-
CRTC-CREB Axis Protects Against Proteotoxic Stress in Drosop
2026-05-20
This study reveals how the CRTC-CREB transcriptional axis acts as a sensor and defender against proteotoxic and oxidative stress in Drosophila, linking proteasome inhibition to CREB activation via ROS/JNK signaling. The findings illuminate conserved mechanisms underlying neurodegenerative diseases and suggest new strategies for therapeutic target identification.
-
AO/PI Double Staining Kit: Precision in Cell Viability Assay
2026-05-20
The AO/PI Double Staining Kit elevates cell viability, apoptosis, and necrosis detection by delivering rapid, high-fidelity results in a single fluorescent assay. Its dual-dye strategy, supported by recent innovations in rare cell profiling, enables researchers to tackle challenging samples—including clinical isolates and advanced cancer models—with unparalleled clarity.
-
GSK621: Advancing AMPK Agonist Strategy in Translational Onc
2026-05-19
Explore the integration of GSK621, a potent AMPK agonist from APExBIO, into translational research strategies for acute myeloid leukemia and tumor immunometabolism. This thought-leadership article provides mechanistic insight, comparative validation, and actionable guidance for leveraging AMPK activation to drive metabolic, apoptotic, and immunological outcomes—grounded in recent scientific advances and practical workflow recommendations.
-
Annexin V-PE Apoptosis Detection Kit: Live-Cell Precision As
2026-05-19
Harness the power of the Annexin V-PE Apoptosis Detection Kit for rapid, fixation-free apoptosis detection in live cells. Discover how optimized protocol parameters and real-world troubleshooting can elevate your cytometry and microscopy results for translational immunology and cell death research.
-
Lyso-Tracker Red: Precision Lysosome Labeling in Live Cells
2026-05-18
Lyso-Tracker Red DND-99 empowers researchers with high-specificity, live-cell lysosome labeling, unlocking advanced analysis of lysosomal dynamics and function. Its robust fluorescence and compatibility with sophisticated workflows make it indispensable for autophagy, pathogen-host interaction, and immunotherapy research.
-
AO/PI Double Staining Kit: Precision Cell Fate Profiling in
2026-05-18
Explore how the AO/PI Double Staining Kit enables high-fidelity cell viability and death profiling even in challenging rare cell isolation assays. This article leverages advanced insights from recent viral nanofiber capture technologies and provides novel guidance for integrating AO/PI double staining into next-generation cancer and liquid biopsy workflows.
-
CGP 55845 Hydrochloride: Precision Tools for GABAB Receptor
2026-05-17
Explore how CGP 55845 hydrochloride, a selective GABAB receptor antagonist, enables advanced studies of neurotransmitter release and synaptic modulation. This article reveals novel assay strategies and practical insights that extend beyond standard protocols.
-
UBC9-Mediated PINK1 SUMOylation Attenuates PD Oxidative Stre
2026-05-16
This study demonstrates that UBC9 promotes SUMOylation of PINK1, enhancing mitophagy and reducing oxidative stress in Parkinson’s disease models. The findings illuminate a novel regulatory axis and propose UBC9 as a potential target for modulating neurodegeneration.
-
Exosomal Egr2 from BMSCs Modulates RNF8/DAPK1 Axis in Ischem
2026-05-15
This study uncovers a mechanism by which bone marrow mesenchymal stem cell (BMSC)-derived exosomal Egr2 protects neuronal cells from oxygen-glucose deprivation/reoxygenation (OGD/R) injury via the RNF8/DAPK1 axis in ischemic stroke. The findings offer new insights into exosome-mediated neuroprotection and suggest experimental strategies for dissecting protein-protein interactions in this context.
-
BHQ-Mediated SERCA Inhibition: Catalyzing Next-Gen HSC Mobil
2026-05-15
This thought-leadership article explores how 2,5-di-tert-butylbenzene-1,4-diol (BHQ) is reshaping hematopoietic stem cell (HSC) mobilization by selectively inhibiting SERCA, inducing mild ER stress, and modulating the CaMKII-STAT3-CXCR4 axis. We analyze mechanistic, translational, and competitive aspects, introduce protocol guidance, and position APExBIO’s BHQ as a cornerstone for advanced calcium signaling research.
-
Protein A/G Magnetic Co-IP/IP Kit: Streamlined Complex Isola
2026-05-14
The Protein A/G Magnetic Co-IP/IP Kit empowers researchers to achieve rapid, reproducible isolation of protein complexes and antibody purification. By leveraging recombinant Protein A/G magnetic beads and optimized buffers, this kit delivers robust performance for mechanistic pathway analysis and translational workflows—especially in challenging applications like neuronal injury models.
-
ML133 HCl: Precision Potassium Channel Inhibitor for Kir2.1
2026-05-14
ML133 HCl is a highly selective potassium channel inhibitor, enabling reproducible control over Kir2.1-mediated processes in cardiovascular and pulmonary artery smooth muscle cell research. With robust protocol parameters and troubleshooting strategies, this tool from APExBIO accelerates mechanistic studies and translational discovery.
-
RESTRICT-seq Reveals KAT6A Epigenetic Dependency in SCC Resi
2026-05-13
The referenced study introduces RESTRICT-seq, a time-gated CRISPR screening platform that uncovers temporally regulated epigenetic dependencies in squamous cell carcinoma (SCC) resistance, notably implicating KAT6A as a critical factor. These findings provide a new mechanistic framework for exploring selective KAT6A inhibition in cancer biology research and inform future strategies for oncogene-induced senescence induction.